Fritextsökning
Artiklar per år
Innehållstyper
-
Läkemedelsverket rekryterar från Abbvie
Läkemedelsverket har utsett Eva Flock till ny kanslichef för Centrum för bättre läkemedelsanvändning, CBL.
-
Tar roll på Quay Pharmaceuticals
Jörn Mars går in som Business Development Director Scandinavia på företaget SGS Quay Pharmaceuticals.
-
Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?
In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.
-
Nanexa develops depot formulation of the diabetes and obesity drug Saxenda
Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The drug is currently approved for the treatment of diabetes and obesity.
-
Nanexa utvecklar depåberedning av diabetes- och fetmaläkemedlet Saxenda
Uppsalabaserade Nanexa har slutit ett avtal med ett tyskt kontraktsforskningsbolag för att starta en klinisk studie med en månadsdepå av liraglutid. Läkemedlet är idag godkänt för användning mot diabetes och vid obesitas.
-
Nytt program ska hjälpa akademisk forskning till marknaden
Steget från akademisk forskning till kommersialisering inom life science är ofta tufft. Nu lanseras ett nytt finanseringsprogram för att överbrygga gapet.
-
Rapid developments in AI – “All stakeholders are struggling to understand it”
Artificial intelligence is being discussed more and more, and developments in the field are moving rapidly. As the Swedish Medical Products Agency testifies, keeping up with developments is not easy.
-
Han tar över som ordförande i CTR
Bengt Dahlström, grundare av Center for Translational Research, har efter sju år som styrelseordförande i koncernen lämnat över ordförandeklubban till Hans Andreasson.
-
Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far
Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, writes Samuel Lagercrantz in an editorial.
-
Swedish and Ukrainian Medical Product Agencies sign an agreement
The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.
-
Uncertainty about the government’s life science work
The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now questions are being raised both about the government’s plans for the office and the Swedish life science strategy.
-
New diagnostic rules raise concerns
In a panel discussion, several voices from academia and the industry expressed concerns about the transition to the new regulatory framework for in-vitro diagnostics (IVDR). They argue that it may create significant differences between regions, and patients may be affected.
-
New drug alert in the US: Rise in overdoses linked to the use of drugs for animals
A combination of the synthetic drugs fentanyl and xylazine, an animal tranquilizer, has been labelled a “growing threat” by the White House due to its role in the ongoing opioid crisis in the US.
-
Hon ska ansvara för Gedeas kvalitetssäkring
Lundabolaget Gedea Biotech har utsett Anna-Karin Areskog till ny QA Director.
-
Han är ny på Navinci Diagnostics
Uppsalabolaget Navinci Diagnostic har nu rekryterat Dr Subham Basu som ny Chief Business Director.
-
He will be the new chair of Medicon Valley Alliance
Niels Abel Bonde is the nomination committee’s proposal and the most likely person to take over as the new chairman of the Swedish-Danish life science cluster organisation Medicon Valley Alliance (MVA).
-
Han blir ny ordförande för Medicon Valley Alliance
Niels Abel Bonde är valberedningens förslag och den som med största sannolikhet tar över som ny ordförande för den svensk-danska klusterorganisationen för life science, Medicon Valley Alliance, MVA.
-
The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality
Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Experts in the field claim that andrology needs to become a speciality in Sweden to increase awareness and knowledge. But the Swedish National Board of Health and Welfare says that it is not a priority.
-
Sobis samarbete med Sanofi ger skörd – läkemedel mot hemofili godkänt i USA
Svenska särläkemedelsbolaget Sobi har fått ett nytt läkemedel mot hemofili A godkänt i USA. I EU väntas en ansökan om godkännande lämnas in senare i år.
-
Editorial: ”AI that both impresses and frightens”
”In the past, I've rarely been particularly impressed by something that was produced by AI. But this is something completely different”, Samuel Lagercrantz writes in an editorial.
-
Hello Jenni Nordborg!
Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.
-
The government proposes fines for pharmaceutical companies that fail to notify drug shortages in time
According to a compilation from the Swedish Medicines Agency, the number of residually notified medicines increased by 54 % in Sweden last year compared to the previous year. In a bill presented by the government a number of proposals are put forward to counteract the problem.
-
God löneutveckling inom life science
Efterfrågan på arbetskraft inom life science ökar och ny statistik från Naturvetarna visar även på en god löneutveckling under fjolåret.
-
Immunovia rekryterar från Roche
Cancerdiagnostikföretaget Immunovia har anställt Lara E Sucheston-Campbell som ansvarig för kliniska och medicinska ärenden, eller Head of Medical and Clinical Affairs.
BREAKING